Navigation Links
Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data

OTTAWA, April 11 /CNW/ - Liponex Inc. (TSX:LPX), a biopharmaceutical company specializing in developing advanced products related to High Density Lipoprotein (HDL), often called "good cholesterol," today announced information from further analysis of the Phase I/II Clinical Trial of its lead product, CRD5. CRD5 is being developed for the treatment of dyslipidemia and heart disease.

A detailed review of patient information indicated that all blood chemistry and blood pressure measurements were within the normal or expected ranges. CRD5 was shown to be safe in dyslipidemic patients. In addition, the drug was well-tolerated in the patient group, with the exception of the reported GI adverse events that led to the cessation of the 5 gram dosing phase.

As previously reported, the overall mean HDL increase was 5% at both the 1g (n=50) and 3g (n=40) dosing levels but the patient to patient variation was high. While some patients had a negative response, over 20% of patients achieved more than a 10% rise in HDL at the lower dose levels.

The patient information was reviewed to determine if there were any patient characteristics that had an impact on the efficacy of CRD5. Some patients were taking other medications during the trial that may have had lipid altering effects and these subjects appeared to have reduced response to CRD5. Data from these subjects were removed and the trial results were reanalyzed. CRD5 appeared to be more effective in patients with baseline plasma HDL-cholesterol levels of less than 0.9 mM. This level of HDL is considered to be abnormal and is associated with elevated risk of developing heart disease. Those patients (n=17) with starting HDL levels below 0.9 mM averaged an 11% increase in HDL levels from baseline at the 3 gram CRD5 dosing level.

Of note, several patients were identified to have taken proton pump inhibitors (PPI), such as ranitidine and lansoprazole,
'"/>




Page: 1 2 3

Related medicine technology :

1. Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Liponex Inc Reports Further Analysis CRD5 Phase Clinical Trial Data
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), ... that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... The terms of the acquisition were not disclosed. ... company providing a wide range of sleep, mobility, and respiratory ...
(Date:1/14/2014)... 14, 2014   NuAire , a manufacturer of ergonomically designed ... Hitachi Koki of Japan to sell ... America . NuAire will utilize its network of sales professionals ... Canada to offer assistance in application use, product benefits ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Equashield's Sales Grow by 60% in 2013 2
(Date:4/23/2014)... pathway that helps prevent new cells from receiving too ... been directly linked to cancer and other diseases. , ... the end of cell division, the enzyme Cdc14 activates ... are fully repaired before the parent cell distributes copies ... safeguard against some of the most devastating genome errors, ...
(Date:4/23/2014)... gastro-intestinal tract has long been considered to be between ... Academy have used refined microscopic techniques that indicate a ... the gastro-intestinal tract is only as large as a ... digestive tract, which passes from the mouth through the ... of about 5 meters in a normal adult, and ...
(Date:4/23/2014)... new computer program could help doctors predict which patients ... treatment. , The program, which assesses brain scans ... airport security and passport control, has been developed by ... study funded by the Wellcome Trust, which used the ... . , Stroke affects over 15 million people ...
(Date:4/23/2014)... MD (April 23, 2014) The American Gastroenterological ... the 2014 AGA Research Scholars. The AGA Research ... investigators to develop independent and productive research careers ... Scholar Awards fund an additional year allowing for ... committed to supporting junior faculty who are paving ...
(Date:4/23/2014)... displayed in the popular Swedish children,s TV show ... foods. A new study from the University of ... TV programmes as well as the link between ... status. , Steingerdur Olafsdottir,s doctoral thesis focuses on ... children,s TV show Bolibompa. Healthy foods dominated in ...
Breaking Medicine News(10 mins):Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:High-calorie and low-nutrient foods in kids' TV 2
... sure what spurs need for early treatment , TUESDAY, ... higher levels of education or disability typically need treatment ... study finds. , The study included 413 patients with ... trials of experimental drugs. The patients were assessed at ...
... , TROIS-RIVIERES, Quebec, July 14 ... beautiful and vibrant cities in all of Canada, and ... is recognized worldwide and has an international reputation for ... the growing drug problems facing Vancouver,s downtown eastside. "Our ...
... compliance, study finds , TUESDAY, July 14 (HealthDay News) -- ... use of a reminder program for women who were due ... Permanente staff checked electronic health records of its 35,000 members ... a mammogram for 20 months. They were sent a postcard ...
... , NEW YORK, July 14 NBC Universal communications ... of Senior Vice President, Communications, NBC Universal Women and Lifestyle Entertainment ... Communications. The announcement was made today by Lauren Zalaznick, President of ... report. , , For the last ...
... ARDEE, Ireland, July 14 Warner Chilcott Limited (Nasdaq: ... financial results prior to the market opening on Friday, August 7, 2009. ... a press release, the Company will host a conference call for all ... to review the results. To participate in the call, please dial (888) ...
... study finds , TUESDAY, July 14 (HealthDay News) -- People ... for heart disease, a U.S. study has found. , The ... home. At physical examinations conducted in 2005 and 2006, the ... in minutes and miles, and the percentage of the journey ...
Cached Medicine News:Health News:Educated Parkinson's Patients Move to Meds Sooner 2Health News:Crime, Drugs and Health Problems Face Vancouver's Downtown Eastside 2Health News:Reminders Boost Mammography Appointments 2Health News:Hilary Smith Upped to Senior Vice President, Communications, NBC Universal Women & Lifestyle Entertainment Networks 2Health News:Walking, Biking to Work Pays Off 2
AxSYM Plus provides cutting-edge ergonomics and smart new features that mean increased ease-of-use and enhanced reliability. Also, advanced software means less operator intervention and high-integrit...
The ADx system uses fluorescence polarization immunoassay technology for the detection of abused drugs and toxicology assays....
The UniCel DxI 800 with its exceptional throughput, proven chemiluminescent technology, assay protocols like Access, Access 2, Synchron LXi 725 and load "on-the-fly" capability simplifies and automat...
...
Medicine Products: